RaNA Therapeutics Receives $55,000,000 Series B Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5fb28ae8-56e5-46e2-bae9-8170cb09d53d
Date 7/23/2015
Company Name RaNA Therapeutics
Mailing Address 790 Memorial Drive Cambridge, MA 02139 USA
Company Description RaNA Therapeutics is a biotechnology company using its proprietary RNA upregulation platform to discover and develop highly selective epigenetic modulators of gene expression. RaNA’s technology upregulates the expression of desirable genes that can prevent or treat disease.